globenewswire news
2026-11-06T03:42:58Z
NEW HOPE, Pa., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact technologies to patients through...
2026-11-06T02:07:17Z
Second annual Congress at the Yale Club of New York City unites health system CEOs, physicians, technologists and investors; Healthcare Shark Tank led by Robert Herjavec fields 360+ startup applications...
2026-11-06T00:26:00Z
Following Dr. Les M. Wong's retirement after 40 years at the Blossom Hill Road location, the practice formerly known as San Jose Smile Design has new ownership and a new...
2026-11-06T00:00:00Z
Positive Article 117 Notified Body Opinion satisfies a key EU regulatory requirement for an advanced cannabis drug-device combination product and supports planned commercialization in the UK and Europe
2026-11-05T23:27:04Z
SAN FRANCISCO, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Ossium Health, a bioengineering company that built the world's first bank of organ donor-derived bone marrow, today announced that four abstracts have...
2026-11-05T22:23:28Z
SAN RAMON, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today it will report fourth quarter and full year 2026 financial...
2026-11-05T22:00:00Z
FREMONT, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced that its Cytek Aurora® Evo system has been named Drug Discovery Innovation...
2026-11-05T21:34:40Z
SOUTH SAN FRANCISCO, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biotechnology company developing engineered natural killer (NK) cell therapies to treat autoimmune diseases, today...
2026-11-05T21:32:00Z
Company to host a conference call and audio webcast tomorrow at 8:00 a.m. ET
2026-11-05T21:30:00Z
IRVINE, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to attend the following upcoming investor conferences:
2026-11-05T21:30:00Z
First participant dosed in QUELL-DME, a Phase 2 trial of BGE-102, a potential best-in-class oral NLRP3 inhibitor, in diabetic macular edema; topline results anticipated in the second half of 2027
2026-11-05T21:17:44Z
GAITHERSBURG, Md., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a drug delivery company built to stop surgical infections, today provided a business update and...
2026-11-05T21:15:00Z
- Varsetatug masetecan (Varseta-M) granted FDA Fast Track designation for relapsed/refractory metastatic colorectal cancer -
2026-11-05T21:10:00Z
Year Over Year Net Revenue Growth of 18% and Core Programmatic Revenue Growth of 8% for the Three Months Ended September 30, 2026
2026-11-05T21:10:00Z
Q3 2026 Net Revenue of $68.2 Million, Up 4.8% Year-Over-Year
2026-11-05T21:07:16Z
Q3 2026 revenue of $32.9 million; GAAP basic EPS: $(0.04)
2026-11-05T21:06:48Z
CERRITOS, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Starling Oncology, Inc. (NASDAQ: STLN) (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United States, today...
2026-11-05T21:05:00Z
SOUTH SAN FRANCISCO, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver...
2026-11-05T21:05:00Z
CANTON, Mass., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine and tissue innovations company focused on empowering healing through the development, manufacture, and...
2026-11-05T21:05:00Z
DEER PARK, Ill., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare...
2026-11-05T21:05:00Z
BALA CYNWYD, Pa., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that previously...
2026-11-05T21:05:00Z
DOYLESTOWN, Pa., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage precision medicine oncology company focused on the discovery and development of...
2026-11-05T21:05:00Z
ROCKVILLE, MD, Nov. 05, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that...
2026-11-05T21:05:00Z
ROMEOVILLE, Ill., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company...
2026-11-05T21:05:00Z
Proteus™ remains on track for anticipated Q2 2027 commercial launch
2026-11-05T21:05:00Z
Delivers revenue growth of 73% in the third quarter and raises full year 2026 revenue guidance
2026-11-05T21:05:00Z
REGULATED INFORMATION
2026-11-05T21:05:00Z
CAMBRIDGE, Mass., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Apnimed, Inc. (Nasdaq: APMD) (“Apnimed” or the “Company”), a late-stage clinical pharmaceutical company dedicated to the discovery, development and commercialization of novel...
2026-11-05T21:05:00Z
Continued progress toward starting SC451 Phase 1/2 trial in type 1 diabetes
2026-11-05T21:05:00Z
45% Revenue Increase and 44% Growth in U.S. Procedure Volume Year-to-date
2026-11-05T21:05:00Z
SAN CLEMENTE, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for...
2026-11-05T21:05:00Z
Received authorization in the United Kingdom and European Union to expand global first-in-human ASCEND Phase 1/2 clinical trial of CMP-002 in patients with SYNGAP1-related disorder, adding to clearances in Australia...
2026-11-05T21:05:00Z
REDWOOD CITY, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (Rezolute or the Company), a late-stage ultra-rare, metabolic disease company focused on treating refractory hypoglycemia caused by...
2026-11-05T21:05:00Z
LONG BEACH, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ: SKIN) (“SkinHealth Systems” or the "Company"), home to flagship brand Hydrafacial®, today announced financial results for the...
2026-11-05T21:05:00Z
MINNEAPOLIS, Nov. 05, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular...
2026-11-05T21:05:00Z
Strengthened leadership with the appointment of Susan G. Kozauer, M.D., as Chief Medical Officer and Joseph Miller as Chief Financial Officer
2026-11-05T21:05:00Z
MediWound Announces Closing of $17.25 Million Bought Deal Offering of Ordinary Shares
2026-11-05T21:05:00Z
Topline data from 400-person sentinel safety cohort and approximately 5,000 patients in main cohort Phase 2b COVID-19 trial anticipated by mid-year 2027
2026-11-05T21:05:00Z
Delivers Strong Q3 With 53% Year-Over-Year Revenue Growth Raises Full Year 2026 Revenue Guidance
2026-11-05T21:05:00Z
- Revenue Increases to $13.6 Million -
2026-11-05T21:05:00Z
MENLO PARK, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional...
2026-11-05T21:05:00Z
NEEDHAM, Mass., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve disease outcomes...
2026-11-05T21:05:00Z
Active Commercial Cancer Center Customers Increased to 26 and Total Commercial Funnel Grows to More Than 65 Centers
2026-11-05T21:05:00Z
Gross margin reaches 78%; cash used in operating activities declines 56% sequentially
2026-11-05T21:05:00Z
LA JOLLA, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat serious autoimmune and inflammatory disorders, today announced that management...
2026-11-05T21:03:00Z
SALT LAKE CITY, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today reported...
2026-11-05T21:02:55Z
SAN FRANCISCO, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Omada Health, Inc. (Nasdaq: OMDA), the virtual between-visit healthcare provider, today reported financial results for the third quarter ended September 30, 2026.
2026-11-05T21:02:00Z
EMERYVILLE, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a late-stage clinical immunology company pioneering transformative therapies for people with neurologic autoimmune diseases, today announced that...
2026-11-05T21:02:00Z
SOUTH SAN FRANCISCO, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) products for...
2026-11-05T21:02:00Z
AUDUBON, Pa., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the third quarter ended September 30, 2026.